340B Drug Pricing - Update on Legislative, Regulatory and Political Landscape

This activity will discuss the 340B legal and regulatory landscape including manufacturer actions regarding contract pharmacies and other regulatory and agency developments. This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.

A Call to Action: Dedicated Medication Safety Transformation in the Perioperative Setting

This activity will focus on the daily challenges of ensuring medication safety in the high-risk perioperative or procedural setting, highlighting the national aggregate findings and practice gaps identified using ISMP's Medication Safety Self Assessment for Perioperative Settings.

A Deep Dive into the Role of PARP Inhibitors: Equipping Healthcare Professionals with the Necessary Tools for Improving Care in Ovarian Cancer

This activity will improve the knowledge and competency of pharmacists, nurses, and other healthcare professionals about the role of PARP inhibitors in ovarian cancer and the management of adverse events associated with PARP inhibitors.

A Review in the Treatment Options for Renal Cell Cancer

This activity will review treatment options for patients with RCC. The pharmacological treatments available, appropriate use, adverse events, monitoring of agents, and management of adverse events will also be discussed. Available for free to NASP members. Visit www.ProCE.com/CSPE for details.

Adherence Concepts for the Cancer Patient

This activity addresses the issue of adherence in the oncology patient. Topics include the incidence, reasons and consequences of non-adherence. Strategies to remove barriers to non-adherence and improve adherence rates will be discussed. Available for free to NASP members-visit www.ProCE.com/CSPE

An Introduction to Gene and Disease-modifying Therapies in Specialty Pharmacy

This activity will briefly review key background information and definitions and then discuss gene therapy, disease-modifying treatments and patient considerations following therapy. Available for free to NASP members. Visit www.ProCE.com/CSPE for details.

Antibiotic De-escalation: Preventing Resistance or Futile Existence?

Expert faculty will debate the pros and cons of Antibiotic De-escalation. Primary literature and guidelines recommendations regarding de-escalation and antibiotic resistance will frame the basis for this discussion as best practices are identified.

Arming Specialty Pharmacies with Standards-Based Technologies to Engage Patients and Prescribers

This activity examines how standards-based technology solutions are aiding specialty pharmacies. Topics include a review of the landscape of specialty pharmacy and standards, specialty pharmacist-related opioid issues and more. Available for free to NASP members. Visit www.ProCE.com/CSPE

Atopic Dermatitis

At the end of this presentation learners should understand the clinical presentation, risk factors and treatment options of Atopic Dermatitis. Available for free to NASP members. Visit www.ProCE.com/CSPE for details.

Best Practices for the Safe and Cost-Effective Management of Controlled Substances

This session will provide guidance to assess an organization’s medication-use processesfor vulnerabilities and identify strategies that may improve the capacity to preventor detect diversion.